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Background: Individuals with autism spectrum disorder (ASD) show atypical scan paths during social interaction and
when viewing faces, and recent evidence suggests that they also show abnormal saccadic eye movement dynamics and
accuracy when viewing less complex and non-social stimuli. Eye movements are a uniquely promising target for studies
of ASD as their spatial and temporal characteristics can be measured precisely and the brain circuits supporting them are
well-defined. Control of saccade metrics is supported by discrete circuits within the cerebellum and brainstem -
two brain regions implicated in magnetic resonance (MR) morphometry and histopathological studies of ASD.
The functional integrity of these distinct brain systems can be examined by evaluating different parameters of
visually-guided saccades.
Methods: A total of 65 participants with ASD and 43 healthy controls, matched on age (between 6 and 44-years-old),
gender and nonverbal IQ made saccades to peripheral targets. To examine the influence of attentional processes,
blocked gap and overlap trials were presented. We examined saccade latency, accuracy and dynamics, as well as the
trial-to-trial variability of participants’ performance.
Results: Saccades of individuals with ASD were characterized by reduced accuracy, elevated variability in accuracy
across trials, and reduced peak velocity and prolonged duration. In addition, their saccades took longer to accelerate to
peak velocity, with no alteration in the duration of saccade deceleration. Gap/overlap effects on saccade latencies were
similar across groups, suggesting that visual orienting and attention systems are relatively spared in ASD. Age-related
changes did not differ across groups.
Conclusions: Deficits precisely and consistently directing eye movements suggest impairment in the error-reducing
function of the cerebellum in ASD. Atypical increases in the duration of movement acceleration combined with lower
peak saccade velocities implicate pontine nuclei, specifically suggesting reduced excitatory activity in burst cells that
drive saccades relative to inhibitory activity in omnipause cells that maintain stable fixation. Thus, our findings suggest
that both cerebellar and brainstem abnormalities contribute to altered sensorimotor control in ASD.
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Impaired social communication abilities and restricted,
repetitive behaviors represent the defining characteristics
of autism spectrum disorder (ASD) [1]. However, the
majority of affected individuals also show sensorimotor
abnormalities that may precede the emergence of social
communication and cognitive deficits early in life [2-5].
Improved understanding of characteristic motor deficits
could therefore facilitate early detection. It also could
provide insight into the pathophysiological mechanisms
of ASD, as the brain systems supporting sensorimotor
control are better understood than those supporting
many higher-level cognitive and social processes.
In additional to atypical visual scan patterns while looking
at faces and during social interactions [6-8], individuals
with ASD show abnormalities in their the sensorimotor
control of eye movements when viewing simple visual
stimuli (illuminated dots on a blackened screen) [9-11] and
human faces [12]. When making rapid shifts in eye gaze
(saccades), individuals with ASD show reduced accuracy
[9,13-15] and increased trial-to-trial variability of saccade
accuracy [9,13,16]. These deficits appear to be more severe
in children compared to adolescents with ASD, suggesting
that the ability to precisely control eye movements may
mature at a delayed rate [14]. Saccade abnormalities also
are sometimes seen in unaffected family members of indi-
viduals with ASD [17], highlighting their promise as endo-
phenotypes for parsing heterogeneity and tracking familial
risk in this disorder.
Some studies of saccade dynamics in individuals with
ASD have documented reduced peak velocity [15] and
increased duration [12,16], while others have not
[9,13,14,18,19]. These inconsistencies may result from
differences in subject samples and methodologies across
studies. Studies utilizing small samples (n ≤15) may lack
power to detect abnormalities that may be variably
present across affected individuals [13,15,16,19]. For in-
stance, one study documented abnormality in saccade
dynamics, particularly in peak velocity, in one participant
with ASD despite no overall group differences [19]. More-
over, some studies examined endogenously-cued or
intentional saccades [12,14-16], and others examined
exogenously-cued or reflexive visually-guided saccades to
targets with unpredictable onset timing and spatial loca-
tion [9,11,13,18,19]. Abnormalities in saccade dynamics
have been noted consistently in tasks when subjects make
endogenously-cued saccades [15,16] which are under sig-
nificant top-down control from the cerebral cortex [20].
Alternatively, studies of visually-guided saccades have had
less consistent findings, perhaps due to testing only small
saccades in some studies, as deficits appear greater in larger
saccades [17,18]. Only one study examined the acceleration
and deceleration of visually-guided saccades, however,
healthy control and ASD groups did not significantly differ[13]. These results may suggest that saccade dynamics are
only affected when cortical brain structures are involved.
However, it is also possible that the small sample sizes and
saccade amplitudes examined in previous studies may have
limited sensitivity to detect abnormalities within cerebellar
and brainstem structures supporting these functions. Fur-
thermore, in contrast to saccade accuracy, there is less evi-
dence supporting developmental improvement in saccade
dynamics in both healthy [21,22] and ASD samples during
childhood and adolescence [14]. However, one study exam-
ining healthy controls across lifespan demonstrated in-
creased peak saccade velocity from early childhood to
adolescence, and subsequent decline in late adulthood [23].
With few studies examining the developmental changes of
saccade dynamics in individuals with ASD, and inconsistent
findings in healthy populations, a better understanding of
these possible age-related changes is needed.
Saccadic eye movements are controlled by highly special-
ized cortico-cerebellar-brainstem circuitry [24]. Saccade ini-
tiation occurs when pontine burst cells are simultaneously
released from their tonic inhibition by omnipause cells and
driven by excitatory signals from the superior colliculus
[24,25]. Thus, the process of reflexive saccade initiation
requires a temporally synchronized excitation of burst cells
and release of those burst cells from tonic inhibitory input.
The reverse of this process terminates saccades. Dynamic
characteristics of saccades including their duration, peak
velocity, acceleration and deceleration depend on the firing
rates of pontine burst cells in the context of their release
from omnipause cell inhibition [26].
Medioposterior lobules VI to VII of the cerebellum and
the caudal fastigial nuclei to which they project act to main-
tain saccade accuracy, compensating for any systematic
error via feedforward input to the brainstem, permitting
precise refocusing of the fovea onto objects of interest
[26-29]. In addition, saccade error can be partially corrected
online, primarily via lobules VI-VII of cerebellum, by redu-
cing or extending the deceleration phase of saccades
[30-33]. Thus, both pontine brainstem nuclei and the cere-
bellum regulate specific aspects of saccades that can be
evaluated relatively independently in order to identify func-
tional abnormalities in these two brain regions.
The brainstem and cerebellum have been implicated
in postmortem and magnetic resonance imaging (MRI)
studies of ASD. Structural MRI studies have demonstrated
pontine alterations that might cause eye movement abnor-
malities [34-38]. Postmortem studies show reduced num-
bers of Purkinje cells in the cerebellar vermis, hemispheres
and deep nuclei [36,39-42], as well as reduced cell counts
in the fastigial nuclei [43]. Structural MRI studies have
documented reduced grey matter volume within the cere-
bellar cortex [44] and hypoplasia of the cerebellar vermis
lobules VI -VII [45,46]. Reduced activation in the cerebel-
lum during saccades has been reported in a functional
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onstrated compromised cerebellar-dependent saccade
adaptation in ASD, which provides perhaps the most direct
neurobehavioral evidence of dysfunction within the cere-
bellar vermis [47,48].
Gap/overlap paradigms are useful for examining sac-
cade latencies during conditions with different levels of
fixations on a central cue [49,50]. This has been shown
to be sensitive to saccade abnormalities in infants at risk
for ASD [4], and is likely to some degree to be influ-
enced by factors associated with visual attention linked
to visual fixation. However, the extent to which latency
differences are due to attentional versus oculomotor
processes remains a topic of debate [51-53]. Previous
studies in ASD using gap/overlap paradigms have
yielded mixed results, with one showing no abnormality
in the overlap effect in participants with ASD [54], and
the other showing a reduced overlap effect [55]. Thus,
the level of alteration in visual attentional engagement
in ASD remains equivocal.
The current study aimed to examine the accuracy and
dynamics of reflexive saccadic eye movements in a rela-
tively large sample of individuals with ASD across a broad
age range in order to evaluate the functional integrity of
cerebellar and brainstem circuitry supporting distinct sen-
sorimotor components of saccade control. Our secondary
aim was to examine the effect of manipulating attention-
shifting processes on saccade latencies utilizing gap/over-
lap paradigms. We hypothesized that individuals with
ASD would show deficits in saccade accuracy, as well as
impairments in saccade dynamics, based upon anatomical
findings in the cerebellar and brainstem systems that sup-
port these functions respectively. We also hypothesized
that attentional deficits would contribute to saccade initi-
ation abnormalities in ASD.
Methods
Participants
A total of 65 individuals with ASD and 43 healthy controls
matched in age (between 6 and 44-years-old), gender ratio
and nonverbal IQ were examined (Table 1). As the oculo-
motor task placed minimal verbal demands on partici-
pants, we matched the ASD and control groups on
nonverbal IQ as opposed to verbal ability. We have used
this approach previously [9-11,47] in order to include a
more representative sample of individuals with ASD who
are known to have more severe verbal deficits compared
to nonverbal deficits [56] and large discrepancies between
verbal and nonverbal abilities [57,58]. Participants with
ASD were recruited from outpatient clinics at the University
of Illinois at Chicago Medical Center and via flyers posted
in the community. A diagnosis of ASD, including autistic
disorder, Asperger’s syndrome or pervasive developmental
disorder-not otherwise specified (PDD-NOS) wasestablished using the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, Text Revision (DSM-IV-
TR) criteria, as confirmed by research reliably trained clini-
cians using the Autism Diagnostic Interview-Revised
(ADI-R; [59]), the Autism Diagnostic Observation Sche-
dule (ADOS; [60]) and by expert clinical opinion (EC,
MM). The participants with ASD were excluded if they
had a genetic disorder associated with ASD (such as Fragile
X syndrome) or a medical history of non-febrile seizures.
Healthy community controls were recruited through
newspaper advertisements. All had a score of less than or
equal to 8 on the Social Communication Questionnaire
[62]. Healthy controls were excluded if they reported a per-
sonal history of psychiatric illness, a first-degree relative
with a major psychiatric illness (such as schizophrenia), or
a first- or second-degree relative with ASD. No participants
had a previous head injury resulting in loss of conscious-
ness, were taking any medications known to affect oculo-
motor function including stimulants, anticonvulsants or
antipsychotics [63], consumed caffeine within 24 hours of
testing, used nicotine within one hour prior to testing or
had corrected far visual acuity of less than 20/40. Indivi-
duals completed the Differential Ability Scales ([64];
N = 75; <18-years-old) or Wechsler Abbreviated Scale of
Intelligence ([65]; N = 33; ≥18-years-old) to assess intellec-
tual abilities. Individuals with a full-scale IQ score of under
80 were not included. Adult participants provided written
consent and minors provided assent in addition to written
consent from their legal guardian. This study was approved
by the Institutional Review Board of the University of
Illinois at Chicago (Protocol #2002-0286 and #2007-0239).
Procedures
Participants were tested in a darkened black room and
positioned in a chin-rest with forehead and occipital re-
straints to minimize head movement. They were seated
60 cm from a 40-inch anti-glare LCD screen monitor
(Samsung SyncMaster 400P; Samsung, Seoul, Korea)
with a resolution of 1024 × 768 and a 75 Hz refresh rate.
Electrodes placed at the lateral and nasal canthi of each
eye and above and below the left eye monitored saccadic
eye movements and blinks, respectively, using direct
current electro-oculography (EOG; Grass Neurodata 12
Acquisition System; Astro-Med, Inc, West Warwick,
Rhode Island, United States). We elected to use EOG ra-
ther than infrared recording in order to assess larger
amplitude saccades (20 to 30 degrees), which our group
and others have shown to be more severely impaired in
ASD [13,17]. EOG signals were digitized at 500 Hz with
a 12-bit A/D converter (DI-720 from Dataq Instruments,
Akron, Ohio, United States). Visual stimuli subtending
0.5 degrees of visual angle were presented in the hori-
zontal plane at eye level (Flash MX Actionscript 2;
Adobe Systems, San Jose, California, United States).
Table 1 Demographic characteristics for participants with ASD and healthy controls
Demographic characteristic Age group ASD (N = 65) Control (N = 43)
Age group (n, %) 6-11 26 (40) 15 (35)
12-18 23 (35) 12 (28)
19+ 16 (25) 16 (37)
Total 65 43
Age in years 6-11 9.4 (1.4) 9.0 (1.6)
12-18 14.0 (1.8) 14.1 (2.0)
19+ 26.3 (7.4) 26.1 (5.1)
Total 15.2 (7.7) 16.8 (8.3)




Full scale IQ 6-11 100 (17)* 113 (15)
12-18 94 (19)* 107 (15)
19+ 102 (18) 110 (8)
Total 98 (18)** 110 (13)
Verbal IQ 6-11 99 (16)** 116 (19)
12-18 93 (22)* 110 (16)
19+ 109 (22) 109 (13)
Total 99 (21) 106 (12)
Nonverbal IQ 6-11 102 (18) 109 (16)
12-18 99 (19) 98 (10)
19+ 100 (22) 109 (8)
Total 100 (20) 106 (12)
















Means (SDs) are presented for age and IQ.
*P <0.05; ** P <0.01.
†ADOS totals are based on revised algorithms [61] except for those participants (n = 22) who completed Module 4.
ªParticipants with ASD in the 19 years of age and older age band have significantly lower ADI Communication Total scores than those in the 12 to 18-years-old
age band (P = 0.040).
ASD, autism spectrum disorder; IQ, intelligence quotient; ADOS, Autism Diagnostic Observation Scale; ADI, Autism Diagnostic Interview-Revised.
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Figure 1 A representative sample of position (bottom), velocity
(middle) and acceleration/deceleration (top) traces of a single
visually-guided saccade. Parameters used to define the dynamics
of each saccade, including the peak velocity and duration of the
movement, and the acceleration and deceleration phases of the
movement are shown in the velocity trace. Deg, degrees; s, seconds.
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sition bands were applied with a gradual transition band
(from pass to no pass) between 20 and 65 Hz for velocity
and position data, and between 30 and 65 Hz for acceler-
ation data. Data from each trial were visually inspected
offline and scored without knowledge of participant char-
acteristics. Trials were assessed to determine the presence
of confounding measurements (such as excessive noise in
the signal, large head movements or failed task compli-
ance). If the scorer judged any of these factors to be
present, the trial was omitted from analyses.
All participants completed a visually-guided saccade task
consisting of one block of 30 gap trials and one block of 30
overlap trials. The order of gap and overlap blocks was
counterbalanced across participants. Gap trials included a
200 ms temporal gap between central fixation offset and
peripheral target onset. In overlap trials, the central fix-
ation target remained present for 200 ms after peripheral
target onset. Trials began with a central target appearing
for 1.5 to 2.5 seconds (varied randomly in 200 ms inter-
vals). Peripheral targets were presented for 1.5 seconds at
unpredictable locations 10, 20 or 30 degrees to the right or
left of center fixation. Participants were instructed to look
towards the peripheral target when it appeared.
Trials were calibrated independently using fixation data
of central and peripheral target locations. Each trial was
manually calibrated by marking stable center fixation prior
to trial onset, and at the target location after the partici-
pant acquired the peripheral target. If signal drift or head
movement occurred during the performance of the task,
trials were recalibrated using within-trial data from fix-
ation of targets of interest as we have done previously
[9,17,18,66-69]. Saccade onset and offset were marked
when eye velocity rose above and below 30 degrees per
second, respectively. Saccades with latencies less than 70
ms were considered anticipatory and not included in ana-
lyses. Trials in which blinks occurred between 100 ms
prior to stimulus presentation and the end of the primary
saccade were not included.
The latency, accuracy and dynamics were measured
for each saccade (Figure 1). Latencies were calculated
based on the difference between peripheral target onset
and saccade initiation. Saccade accuracy was examined
using the absolute value of the spatial error in degrees of
primary saccades relative to peripheral target position.
We measured the absolute value of spatial error between
primary saccade amplitude and target location because
we have previously observed both hypometric (target
undershoot) and hypermetric (target overshoot) saccades
in participants with ASD [9]. The mean number of sac-
cades made to acquire the peripheral targets was com-
puted for each individual.
The peak velocity and duration of each saccade were
measured. As the velocity and duration of saccades increasewith increasing saccade amplitudes according to a ‘main
sequence’ [70], we also examined velocity:amplitude and
duration:amplitude relationships. We compared the slopes
of both the velocity:amplitude and duration:amplitude rela-
tionships to identify between-group differences. In addition,
we measured peak acceleration, peak deceleration, the time
from saccade onset to peak saccade velocity (duration of
saccade acceleration) and the time from peak saccade
velocity to the end of the saccade (duration of saccade de-
celeration). Lastly, we examined variability of saccade ac-
curacy, velocity, duration, acceleration, deceleration, the
durations of saccade acceleration and deceleration and la-
tency by calculating their standard deviation across trials
for each subject.
We used a series of 2 × 3 × 2 analysis of variance to
examine the effects of diagnostic group (ASD versus
control), target location (10° versus 20° versus 30°) and
condition (gap versus overlap) on saccade performance.
No effects of the direction of eye movements or interac-
tions between saccade direction and diagnostic group
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ward and leftward target displacements. To examine sac-
cade performance across development, we contrasted
group differences at three different developmental stages
(childhood: 6 to 11 years of age versus adolescence: 12
to 18 years of age versus adulthood: 19 and older), which
were chosen based on our previous work investigating
developmental trajectories of motor performance in
ASD relative to healthy individuals [71].
Results
Latency
As expected, the latencies of saccades during overlap tri-
als were longer than those during gap trials (Table 2; F
(1,104) = 297.81; P <0.001). The extent to which overlap
trial saccades were delayed relative to gap trial saccades
did not differ between groups (F(1,104) = 2.63; P = 0.108).
No differences in mean saccade latencies were seen
between participants with ASD and healthy controlsTable 2 Saccade accuracy and latencies for participants
with ASD and healthy controls
ASD Control
Saccade error (absolute value in degree of visual angle)
10 deg 1.46 (0.43)* 1.27 (0.07)
20 deg 2.40 (0.72)*** 1.86 (0.11)
30 deg 3.33 (1.12)** 2.60 (0.17)
Trial-wise variability (SD) of saccade error (absolute value in degrees)
10 deg 1.11 (0.37) 1.03 (0.37)
20 deg 1.90 (0.58)*** 1.31 (0.58)
30 deg 2.79 (0.58)** 2.07 (0.29)
Saccade amplitude in degrees
10 deg 9.78 (0.82) 9.69 (0.82)
20 deg 19.11 (1.28) 19.20 (1.28)
30 deg 27.71 (1.68) 28.14 (1.68)
Trial-wise variability (SD) of saccade amplitude in degrees
10 deg 1.91 (0.64) 1.86 (0.65)
20 deg 2.75 (0.83)* 2.30 (0.83)
30 deg 3.86 (1.19)*** 2.10 (1.19)
Saccade latency in ms
10 deg 255 (52) 248 (52)
20 deg 275 (58) 273 (58)
30 deg 313 (55) 300 (55)
Trial-wise variability (SD) of saccade latency in ms
10 deg 80 (30)** 64 (21)
20 deg 90 (37)** 66 (37)
30 deg 90 (32)* 75 (32)
Mean (SD).
*P <0.05; **P <0.01; *** P <0.001.
ASD, autism spectrum disorder; SD, standard deviation; ms, milliseconds; deg,
degrees.(F(1,104) = 0.57; P = 0.454), however participants with
ASD showed greater trial-to-trial variability in their sac-
cade latencies (Figure 2; F(1,103) = 9.90; P = 0.002).
Accuracy
Participants with ASD and healthy controls had similar
mean amplitudes of primary saccades (F(1,104) = 0.47;
P = 0.496), but trial-wise variability of primary saccade
amplitudes was increased in ASD (F(1,103) = 12.44;
P = 0.001), especially for larger saccades (F(2,102) = 15.31;
P <0.001). Participants with ASD demonstrated an increase
in the absolute error of their saccades, thus showing re-
duced accuracy (Table 2; Figure 3; F(1,104) = 17.40;
P <0.001). This deficit was more severe at larger target step
amplitudes (F(2,103) = 4.23; P = 0.024). ASD participants
also showed greater trial-to-trial variability of saccade error
(Figure 3; F(1,103) = 19.13; P <0.001), which was again
more pronounced at larger target step amplitudes (F
(2,102) = 5.17; P = 0.014). Thus, increased saccade vari-
ability reflected both saccade under-shooting and over-
shooting rather than consistent hypo- or hypermetria.
Number of corrective saccades
As the number of saccades made to acquire targets was
non-normally distributed, non-parametric tests were used
to test for group differences. Individuals with ASD and
controls did not differ in the number of saccades made to
acquire peripheral targets, regardless of the size of target
displacement (Mann-Whitney U test = 1353; P = 0.780).
The number of saccades made to acquire the target was
related to saccade error (ASD: Spearman’s rank correlation
coefficient, or Spearman’s rho = 0.28; P = 0.025; control:
rho = 0.48; P = 0.001) and error variability across trials
(ASD: rho = 0.28; P = 0.026; control: rho = 0.35; P = 0.034)
in both groups. Thus, as expected, participants with ASD
and healthy controls with greater saccade error and error
variability made more saccades to acquire peripheral
targets.
Saccade dynamics
Peak saccade velocities were reduced in ASD (Table 3;
Figure 4; F(1,103) = 3.98; P = 0.049). This deficit was still
evident after correcting velocity measures for saccade
amplitudes (F(1,102) = 5.24; P = 0.024), thus, the velocity
reduction did not result from smaller amplitude sac-
cades in the patient group. Peak saccade velocity was
not related to accuracy or variability of accuracy in
either group (Additional files 1 and 2; P’s >0.077). The
variability of peak velocities across trials was not differ-
ent between groups (F(1,100) = 0.10; P = 0.754).
Saccade duration was increased in participants with ASD
compared to controls (Figure 4; F(1,104) = 4.17; P = 0.044).
The ratio of saccade duration:amplitude also was elevated
in participants with ASD (F(1,104) = 8.11; P = 0.005),
Figure 3 Individuals with ASD showed reduced accuracy of
saccades compared to healthy controls. Absolute error of saccades
in degrees of visual angle was increased in individuals with ASD (top).
Individuals with ASD also demonstrated increased trial-to-trial variability
of saccade accuracy compared to controls (bottom). Both abnormalities
were greater for larger saccades at 20 and 30 degrees compared to 10
degrees. *P <0.05; **P <0.01; ***P <0.001. ASD, autism spectrum disorder;
Con, control; Deg, degrees.
Figure 2 Cumulative frequency plot of gap and overlap saccade
latencies for participants with ASD and healthy controls.
Saccade latencies for overlap trials were significantly greater across
participants. The extent to which latencies increased did not differ
between groups, but latency variability was increased in ASD. ASD,
autism spectrum disorder; Con, control.




10 deg 302 (46)* 317 (44)
20 deg 418 (64)* 442 (62)
30 deg 465 (77) 478 (74)
Saccade duration (ms)
10 deg 61 (11)** 56 (10)
20 deg 80 (11) 77 (10)
30 deg 107 (17)* 103 (16)
Peak acceleration (deg/s/s)
10 deg 20399 (615) 21850 (747)
20 deg 24025 (646) 25697 (785)
30 deg 25865 (695) 26746 (844)
Duration of acceleration (ms)
10 deg 29.93 (5.85)** 27.26 (5.84)
20 deg 37.07 (6.14)* 35.01 (6.14)
30 deg 47.26 (8.40)* 43.46 (8.40)
Peak deceleration (deg/s/s)
10 deg 17997 (561) 18849 (681)
20 deg 19756 (627) 20373 (762)
30 deg 19188 (674) 18383 (820)
Duration of deceleration (ms)
10 deg 33.58 (5.58) 31.03 (5.58)
20 deg 45.46 (6.87) 45.02 (6.87)
30 deg 61.77 (11.01) 62.38 (11.01)
Mean (SDs). ASD, autism spectrum disorder; Deg, degrees; Deg/s, degrees per
second; Ms, milliseconds; Deg/s/s, degrees per second per second.
*P <0.05; **P <0.01.
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4.38; P = 0.015). Saccade duration was not related to accur-
acy or variability of accuracy in either group (P’s >0.109).
The trial-to-trial variability of saccade duration did not dif-
fer between groups (F(1,103) = 2.88; P = 0.093).
Although mean ratios of saccade velocity:amplitude and
saccade duration:amplitude were significantly reduced and
elevated in individuals with ASD, respectively, we found no
group differences in the slopes of the saccade main se-
quence with either parameter (Additional file 3; P’s >0.429).
Thus, individuals with ASD demonstrated abnormalities in
velocity and duration that were consistent across saccade
amplitudes.
Acceleration and deceleration of saccades
Individuals with ASD and healthy controls had similar
peak saccade accelerations (F(1,102) = 0.06; P = 0.804)
and decelerations (F(1,102) = 0.2.02; P = 0.158). There
was also no difference in trial-wise variability of peak
Figure 4 Individuals with ASD showed reduced peak saccade
velocities and increased saccade durations. Individuals with ASD
had reduced peak saccade velocities compared to healthy controls
(top). The duration of their movements was increased compared to
controls (bottom). *P <0.05; **P <0.01. ASD, autism spectrum
disorder; Con, control; Deg, degrees.
Figure 5 Individuals with ASD took longer to reach peak
velocity than healthy controls. The time spent accelerating
saccades was increased in ASD compared to healthy controls (top).
Individuals with ASD showed similar durations of the deceleration
phase of their saccades (bottom). * P <0.05; **P <0.01. ASD, autism
spectrum disorder; Con, control; Deg, degrees.
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ation (F(1,100) = 1.91; P = 0.170) across groups.
However, individuals with ASD took more time to ac-
celerate saccades to peak velocity than controls (Figure 5;
F(1,104) = 6.35; P = 0.013). There was no group differ-
ence in the amount of time spent decelerating saccades
(Figure 5; F(1,104) = 0.38; P = 0.541). Increased time
spent accelerating saccades was not related to saccade
accuracy (Additional file 1; r = −0.18; P = 0.354) or vari-
ability of accuracy (r = −0.06; P = 0.625) in ASD. How-
ever, increased time spent decelerating saccades was related
to lower saccade error (r = −0.29; P = 0.021) and less vari-
ability of saccade error in ASD (r = −0.26; P = 0.039). Accel-
eration and deceleration durations were not related to
accuracy measures in healthy controls (See Additional
file 2). No group differences were found in the trial-wise
variability of time spent accelerating (F(1,102 = 1.54; P =
0.217) or decelerating (F(1,102) = 2.30; P = 0.133) saccades.
Notably, impairments in saccade accuracy and saccade
dynamics or the variability of these saccade measures
were not significantly correlated in ASD (Additional files1, 4 and 5). This suggests that different individuals with
ASD express these two deficits separately, that alterations
in brain systems regulating one saccade parameter is
not the cause of dysfunction in the other, and that differ-
ent brain systems are implicated by the two sets of
abnormalities.Age-related changes in saccade accuracy and dynamics
Age-related reductions in saccade error (F(2,100) = 5.72;
P = 0.004), saccade error variability (F(2,99) = 7.769; P =
0.001) and saccade amplitude variability (F(2,99) = 5.484;
P = 0.006) were observed. Saccade latency (F(2,100) =
11.794; P <0.001) and saccade latency variability across
trials (F(2,99) = 15.634; P <0.001) were reduced with in-
creasing age of participants.. None of the age-related im-
provements in saccade performance differed between
participant groups (Additional files 6, 7, 8 and 9; P’s >
0.384), suggesting that deficits of patients relative to age-
matched peers were relatively consistent across the age
range studied. Saccade dynamics (such as velocity and
Schmitt et al. Molecular Autism 2014, 5:47 Page 9 of 13
http://www.molecularautism.com/content/5/1/47duration) demonstrated no developmental change in ei-
ther group (P’s >0.176).
Clinical correlations
Saccade variables were not associated with intellectual
functioning in either group (P’s >0.081). In participants
with ASD, no saccade variable was significantly associated
with clinical ratings of ASD features on the ADI-R or
ADOS (P’s >0.177).
Discussion
The present study examined visually-guided saccades to
assess the functional integrity of cerebellar and brain-
stem sensorimotor systems and visual attention systems
in ASD. Analyses revealed five key findings. First, partic-
ipants with ASD demonstrated decreased accuracy of
saccadic eye movements, and the accuracy of their sac-
cades was more variable across trials. The increased vari-
ability in performance suggests a deficit in the cerebellar
variability-reducing functions, leading to a reduced cap-
acity for making compensatory adjustments to ensure
consistent and accurate saccade execution. This replicates
earlier findings [9,13-16] indicating functional disturbances
within cerebellar systems controlling the accuracy and
consistency of eye movement trajectories, an interpret-
ation that is supported by recent observations of saccade
adaptation abnormalities in ASD [47,48]. Second, peak
saccade velocities were lower and durations were longer
in participants with ASD. These abnormalities in peak vel-
ocity and duration suggest reduced pontine brainstem
burst cell excitatory activity and/or increased omnipause
cell inhibitory activity that alter the metrics of saccadic
eye movements. These deficits were consistent across sac-
cade amplitudes.
Third, patients spent more time accelerating saccades to
reach peak velocity but not decelerating them. This abnor-
mal eye movement activity has not been reported previ-
ously in ASD. It suggests poor temporal synchronization
of burst cell and omnipause cell activity within pontine
nuclei, with excessive inhibition or reduced excitatory
drive in the early phase of saccade execution. A similar
pattern of a protracted acceleration phase during finger
movements has also been reported in ASD [72], thus ab-
normal input to multiple motor systems from the cerebel-
lum could contribute to movement acceleration deficits
across effector systems. Fourth, age-related improvements
in saccade performance were similar across patient and
control groups, suggesting a similar developmental pro-
file of oculomotor function in ASD as in neurotypical
individuals across the age span studied. Last, partici-
pants with ASD were not differentially impacted by gap
and overlap conditions relative to controls, failing to
provide evidence for an alteration in exogenous visual
attentional systems in ASD. Mean response latenciesalso were unimpaired. Both of these observations are
consistent with prior reports that automatic visual
orienting attention systems are not impaired in ASD
[9,13,14,73]. However, increased latency variability in
participants with ASD does indicate increased variabil-
ity in attentional control.
Our characterization of saccade deficits in ASD is more
analogous to patterns seen in patients with ataxia than other
common neurodevelopmental or neuropsychiatric disorders
[67,74]. Individuals with spinocerebellar ataxia [75] and
Friederich’s ataxia [76] show a similar pattern of reduced
velocity, increased duration and dysmetria as seen in our
patients. Notably, however, prolonged saccade duration in
these samples occurs in the deceleration phase, and so the
pattern we observed is a distinct one. Evidence of impaired
saccade accuracy has been reported in Reading Disorder
[77] and Tourette’s syndrome [78], but neither patient
sample has been shown to have alternations in saccade dy-
namics. Thus, our findings of saccade deficits in ASD seem
more indicative of a fundamental motor disturbance, rather
than a problem of higher neurocognitive control.
Saccade accuracy
Consistent with previous reports by our group and others
[9,13-15], we demonstrated saccade dysmetria in ASD. Four
findings regarding our observation of reduced saccade ac-
curacy are noteworthy. First, participants with ASD showed
greater trial-to-trial variability in the accuracy of their sac-
cades, indicating that increased variability in motor preci-
sion is present not only across affected individuals, but also
within individual patients. Second, participants with ASD
showed more pronounced dysmetria when making larger
saccades, indicating that patients become more impaired
when demands on the motor system are increased, a find-
ing previously found by our group and others [13,17,18].
Third, despite the increased saccade amplitude error,
we found no evidence of reduced saccade amplitudes, in
contrast to prior reports of hypometria in ASD [9,13-15].
Instead, our data demonstrated both hypometric and hy-
permetric saccades in ASD, with average saccade ampli-
tude similar to that of healthy controls. The larger range
of saccade amplitudes assessed and the use of multiple
peripheral targets in the current study may contribute to
the difference in our findings relative to previous studies.
Fourth, despite an increase in error variability in ASD, the
patient group did not demonstrate an increase in trial-to-
trial variability of the duration of saccade deceleration,
reflecting a failure to use online feedback processes to re-
duce saccade error.
One mechanism whereby the cerebellum controls
movement accuracy is via online adjustments to the dur-
ation of eye movements, which occurs primarily during
the deceleration phase of the saccade [31]. Cerebellar
projections originating in the oculomotor vermis and
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and omnipause neurons to modulate saccade durations
and amplitudes [29,79]. Thus, input from the cerebellum
to the brainstem can reduce saccade error by providing a
command to extend or reduce the duration of dysmetric
movements so they end closer to the target location
[25,31,33,80,81]. The observations that the trial-wise vari-
ability of saccade deceleration duration were not increased
in ASD despite the increased variability in saccade accur-
acy suggests a reduced ability to either estimate expected
error during saccade execution or to use those estimations
to modify saccades in transit to reduce their spatial error.
Our findings thus indicate a deficit in the variability-
reducing function of the cerebellum in ASD, resulting in
both hypometric and hypermetric saccades. Purkinje
cells of the dorsal cerebellar vermis are the sole output
of the cerebellar cortex, and these cells are known to
play a major role in controlling endpoint accuracy of
saccades [33,82,83]. Selective damage to the oculomotor
vermis within the cerebellum (lobules VI to VII) pro-
duces increased trial-to-trial variability of saccades in
both non-human primates and in clinical studies, similar
to findings observed in the present study [27-29,31,84].
This neurobehavioral evidence of impaired variability-
reducing function in the cerebellum is consistent with
postmortem studies documenting cerebellar histopath-
ology in ASD, including reduced size and density of
Purkinje cells [39,42,44-46].
Saccade dynamics
One possible explanation for the altered saccade velocity
and duration, and the extended acceleration but not de-
celeration phase of the saccade in our ASD participants,
is an imbalance of excitatory and inhibitory signaling in
the pontine brainstem. Duration of activity in pontine
burst neurons is tightly correlated with saccade duration
[85] and likewise, firing rates of the burst neurons are
highly related to peak saccade velocity [86]. Omnipause
cells tonically inhibit burst cells prior to a saccadic eye
movement, and then become active again to terminate
the movement. The increased time to accelerate sac-
cades thus implicates enhanced inhibitory activity of
pontine omnipause cells, diminished excitatory activity
of burst cells or a reduced ability to synchronize the on-
set and offset of excitatory and inhibitory signaling. Our
observation of altered saccade accelerations is consistent
with prior anatomical studies of individuals with ASD
documenting hypoplasia and cellular pathology within
pontine nuclei [34,35]. Although the brainstem is impli-
cated by our data and prior ASD research, future studies
are needed to confirm that the observed eye movement al-
ternations directly result from brainstem abnormalities.
Alternatively, changes in altered saccade dynamics
might result from abnormal upstream input to the ponsfrom the superior colliculus, basal ganglia or cortical eye
fields. Superior colliculus activity is known to influence
saccade duration, peak velocity and acceleration [87-90],
and also sends indirect input to pontine circuitry via the
central mesencephalic reticular formation (cMRF) [24].
cMRF firing patterns regulate omnipause firing activity
at the beginning and end of saccades [90]. Thus, it is
possible that altered omnipause and burst cell firing
rates may be a downstream effect of impairment within
the superior colliculus, in its input or in the pathways
between superior colliculus and excitatory and inhibitory
pontine cells. While involvement of cortical eye fields and
basal ganglia in these saccade dynamic abnormalities is
possible, dysfunction in either region would be expected
to have led to atypical gap/overlap effects, which were not
seen in our study [24].
Another possibility is that the prolonged acceleration of
eye movements could result from cerebellar dysfunction
given the dense afferent and efferent projections between
the cerebellum and pontine nuclei [29,79,91,92]. Greater
feedforward drive from the cerebellum to pons might ex-
tend saccade acceleration, but in this case similar alter-
ations during the deceleration phase would be expected
and these were not presently seen. Also, the independence
of saccade accuracy and all movement dynamics provides
evidence for a dissociation of abnormalities in the cerebel-
lum and brainstem systems in ASD, which indicates that
abnormal cerebellar input is not likely to be the primary
cause of pontine dysfunction.
Developmental improvements
Age-related improvements of saccade accuracy, saccade
accuracy variability, saccade latency and saccade latency
variability are consistent with prior findings in healthy
control populations [21,23,71]. These findings are con-
sistent with previous literature showing similar develop-
mental trajectories of saccade latency [14,93] and latency
variability [93] in ASD and healthy control individuals
across childhood and adolescence. Despite abnormalities
of saccade accuracy and accuracy variability in ASD, in-
dividuals with ASD appear to benefit from developmen-
tal processes with a trajectory similar to that of healthy
controls, at least in regard to the sensorimotor processes
and age range examined in this study. Thus, these sac-
cade abnormalities appear to reflect deficits emerging in
childhood, if not earlier, that persist into adulthood. One
implication of this pattern is that these deficits may be a
useful biomarker for early detection but studies tracking
these impairments to the first years of life are needed to
characterize their onset and course.
Clinical relationships
We observed no significant relationships between saccade
measures and clinical features of ASD. Oculomotor
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cuits which are notably distinct from those believed rele-
vant to the social communication deficits and restricted,
repetitive behaviors in ASD. Thus, even though sensori-
motor deficits are present in the majority of individuals
with ASD, they may represent additional neural system
dysfunctions in ASD bearing limited relationship to those
impacting neural substrates related to the disorder’s core
diagnostic features. Furthermore, although we did not find
evidence of a relationship between oculomotor dysfunc-
tions and clinically-rated social communication abnormal-
ities in ASD, it is possible that the observed alterations in
saccade accuracy and dynamics are related to the ability to
coordinate gaze during social interactions or when pro-
cessing faces, as suggested by previous eye-tracking stud-
ies [6,7]. Reduced ability to consistently modulate saccadic
eye movement amplitudes could negatively impact early
social experiences, which could have downstream effects
on social and cognitive developments [8,94].
Conclusions
This study provides novel evidence that the accuracy and
dynamics of visually-guided saccades are abnormal in ASD,
implicating both cerebellum and brainstem systems in this
disorder. Our findings are distinct from those that have
been reported in other common neurodevelopmental and
neuropsychiatric disorders, suggesting that these deficits
may be unique to ASD, and provide biomarkers and/or
endophenotypes for future research into this heterogeneous
disorder. Our neurophysiological and functional observa-
tions are consistent with previous anatomic evidence from
in vivo morphometric and postmortem studies that have
demonstrated abnormalities in cerebellar and brainstem re-
gions. Compromised cerebellar and brainstem function
suggest that neural systems other than those related to key
diagnostic features of ASD are affected in this disorder.
These may lead to sensorimotor coordination impair-
ments which impact on multiple aspects of day-to-day
functioning [95].
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